ABSTRACT
Cysteinyl-leukotrienes (cys-LTs) have well-characterized physiopathological roles in the development of inflammatory diseases. We have previously found that protein tyrosine phosphatase ε (PTPε) is a signaling partner of CysLT1R, a high affinity receptor for leukotriene D4 (LTD4). There are two major isoforms of PTPε, receptor-like (RPTPε) and cytoplasmic (cyt-)PTPε, both of which are encoded by the PTPRE gene but from different promoters. In most cells, their expression is mutually exclusive, except in human primary monocytes, which express both isoforms. Here, we show differential PTPε isoform expression patterns between monocytes, M1 and M2 human monocyte-derived macrophages (hMDMs), with the expression of glycosylated forms of RPTPε predominantly in M2-polarized hMDMs. Using PTPε-specific siRNAs and expression of RPTPε and cyt-PTPε, we found that RPTPε is involved in monocyte adhesion and migration of M2-polarized hMDMs in response to LTD4. Altered organization of podosomes and higher phosphorylation of the inhibitory Y-722 residue of ROCK2 was also found in PTPε-siRNA-transfected cells. In conclusion, we show that differentiation and polarization of monocytes into M2-polarized hMDMs modulates the expression of PTPε isoforms and RPTPε is involved in podosome distribution, ROCK2 activation and migration in response to LTD4.
INTRODUCTION
Macrophages are a crucial component of the innate immune system and their presence throughout the various tissues of the organism is fundamental to homeostasis. They clear pathogens, heal damaged tissues and regulate multiple immune and inflammatory responses. However, excessive infiltration and activation of macrophages may destabilize this precarious equilibrium and exacerbate pathological processes, such as neurodegenerative diseases, metabolic syndromes, cancer development and chronic inflammatory disorders, such as allergic asthma (Schultze et al., 2015; Wynn et al., 2013).
In the particular context of asthma, where the airways are continuously challenged by a variety of foreign substances, alveolar macrophages (AMs), located on the alveolar epithelial surface, have the ability to maintain physiological homeostasis of the lungs by tempering allergic inflammation (Mayernik et al., 1983; Toews et al., 1984; Gant et al., 1992). Under an allergic challenge, resident AMs proliferate locally (Jenkins et al., 2011) or differentiate from interstitial macrophages (IMs), located within alveolar walls (Thomas et al., 1976; Landsman and Jung, 2007), and constrain allergic airway inflammation, thus sustaining homeostasis. However, when inflammation is established, polarized AMs represent a continuum of activation phenotypes (Murray et al., 2014; Xue et al., 2014), losing their homeostatic commitment and gaining pathogenic functions. Indeed, higher numbers of M2 macrophages are found in bronchial alveolar lavage from asthmatic patients when compared with healthy subjects (Girodet et al., 2016; Draijer et al., 2013, 2017), and in mice challenged with house dust mites (Lee et al., 2015). Additionally, lung-recruited monocytes have been shown to exacerbate the perceived allergic reaction (Zasłona et al., 2014; Lee et al., 2015). Regulation of migration of macrophage precursors may thus be seen as a therapeutic objective in order to facilitate the resolution of inflammation and to re-establish immune homeostasis in these patients.
Cysteinyl-leukotrienes (Cys-LTs), which comprise LTC4, LTD4 and LTE4, are potent inflammatory mediators and have well-characterized pathophysiological roles in the development and progression of asthma, including inflammatory cell recruitment (Hay et al., 1995). For instance, LTD4, via its high affinity receptor, CysLT1R (Lynch et al., 1999), induces myeloid cell chemotaxis (Thivierge et al., 2001, 2006, 2009) and cytoskeleton rearrangement through Rho signaling (Saegusa et al., 2001; Massoumi et al., 2002). Of note, CysLT1R antagonists are widely used in allergic asthma treatment (Scott and Peters-Golden, 2013).
In order to enter the alveolar space during allergic inflammation, recruited monocytes must get through the vasculature and the interstitial pulmonary tissues (Landsman and Jung, 2007) using a succession of migration movements. The type of physical barrier by which a cell is confronted dictates the migration mechanism that will be employed (Van Goethem et al., 2010, 2011; Guiet et al., 2011). Hence, monocytes, at first, can slip through a porous matrix using amoeboid-type migration. Defined by a round cell shape and the absence of robust adherence, this first migration type is mostly used by leukocytes. Macrophages, on the other hand, are unique among leukocytes in being able to use proteolysis to break through denser tissues (Van Goethem et al., 2010; Guiet et al., 2011), with long membrane protrusions and strong integrin interactions that define a mesenchymal-type migration (Cougoule et al., 2012). These two migration processes are divergent in their signaling pathways, as amoeboid migration is Rho kinase (ROCK)-dependent, whereas mesenchymal migration is enhanced following ROCK inhibition (Gui et al., 2014).
ROCK, a serine/threonine kinase, is among the best-characterized downstream effector of the Rho family of small GTPases. Two isoforms of the kinase have been identified so far – ROCK1 and ROCK2 – and both are activated by various mechanisms: autologous binding of the C-terminus (Amano et al., 1997, 1999), conformational change induced by RhoA binding (Matsui et al., 1996; Doran et al., 2004), binding of lipid messengers (Feng et al., 1999), proteolytic cleavage (Sebbagh et al., 2001, 2005) and phosphorylation (Lowery et al., 2007; Lee and Chang, 2008; Lee et al., 2010; Pan et al., 2013; Chuang et al., 2012, 2013). However, phosphorylation of the residue Tyr-722 of ROCK2 is considered inhibitory as it prevents RhoA-mediated ROCK2 activation and adds an additional regulatory step in ROCK2-induced myosin light chain phosphorylation (Amano et al., 1996; Kawano et al., 1999). The actomyosin system is necessary to generate the contractile force and cytoskeleton reorganization essential for pleiotropic cellular processes, including apoptosis and proliferation, but is also necessary for the rounding and adhesion mechanisms guiding amoeboid cell migration (Amano et al., 2010). On the other hand, mesenchymal migration, facilitated by podosomes (Calle et al., 2006; Carman et al., 2007), is impeded by excessive ROCK signaling, causing an actomyosin-dependent disassembly of these specialized punctate adhesion structures (Kuo et al., 2018; Yu et al., 2013; van Helden et al., 2008; Pan et al., 2011).
Podosomes have long been described as part of the primary adhesion machinery of macrophages, but they are formed by most cells of the myeloid lineage (Linder, 2007). As specialized adhesion structures, podosomes are microscopically defined as F-actin-rich dots surrounded by a ring of cytoskeletal proteins connecting integrins to the actin cytoskeleton (Linder, 2007). They are found either isolated or arranged in superstructures, such as clusters, rosettes or belts, and are interconnected through a network of actin filaments (Panzer et al., 2016; Luxenburg et al., 2007; Bhuwania et al., 2012). Regulation of these filaments is crucial for the optimal actomyosin tractive force required for cell migration (Collin et al., 2008; van den Dries et al., 2013; Evans et al., 2003).
A major regulator of podosome arrangement in osteoclasts is the protein tyrosine phosphatase ε (PTPε) (Chiusaroli et al., 2004; Granot-Attas et al., 2009; Finkelshtein et al., 2014). In these cells, the podosome belt structure is crucial for efficient bone resorption and PTPε regulates ROCK activity, thus leading to proper assembly, dynamics, and subcellular organization of these podosomes (Granot-Attas et al., 2009; Chiusaroli et al., 2004). Accordingly, Ptpre−/− (hereafter PTPε−/−) mice exhibit an increase in bone mass, which coincides with defective osteoclast bone adhesion and resorption as a consequence of disorganized podosomes.
PTPε is represented by five different isoforms (all of which are encoded by a single PTPRE gene); the receptor-type (RPTPε), which presents multiple glycosylated forms depending on its two extracellular asparagine residues (Asn-23, Asn-30), and four non-transmembrane, cytoplasmic (cyt)-PTPε isoforms [cyt-PTPε, p67 (Gil-Henn et al., 2000), p65 (Gil-Henn et al., 2001) and cyt-PTPεD1 (Wabakken et al., 2002)]. RPTPε and cyt-PTPε are the most abundantly expressed and are generated by the use of alternative promoters (Tanuma et al., 1999). RPTPε has two putative glycosylation sites. The role of the glycosylated form of RPTPε has not been directly studied; however, Berman-Golan and Elson (Berman-Golan and Elson, 2007) observed that in mammary tumor cells it was only the glycosylated form of RPTPε that was phosphorylated by Neu (also known as ERBB2) and thus could activate Src.
In the majority of murine cell types examined, cyt-PTPε and RPTPε expression is mutually exclusive (Elson and Leder, 1995). However, we have previously shown that both isoforms are expressed in human primary monocytes (Lapointe et al., 2019). Their divergent pattern of expression in polarized human monocyte-derived macrophages (hMDMs) is the focus of the present study.
Here, we present a characteristic expression pattern of RPTPε in M2-polarized hMDMs. We also examine the involvement of this isoform in migration, through the regulation of ROCK2 Tyr-722 phosphorylation and podosome arrangement. Moreover, we show that mutation of the putative N-glycosylated Asn-23 residue of RPTPε results in increased ROCK2 Tyr-722 phosphorylation.
RESULTS
cyt-PTPε and RPTPε expression is differentially modulated by cytokines in human primary monocytes
Regulation of PTPε expression has not been fully studied in human cells. However, unlike rat and murine cells, human primary monocytes express cyt-PTPε and RPTPε simultaneously (Lapointe et al., 2019). To follow up on this observation, we were interested in examining the modulation of expression of PTPε isoforms in these cells as they are the precursors of hMDMs in vitro and macrophages in vivo.
We have previously shown that cyt-PTPε and RPTPε were involved in LTD4-induced CysLT1R signaling (Lapointe et al., 2019) with cyt-PTPε having the predominant role in IL-8 production. Here, we first studied the effect of LTD4 on cyt-PTPε and RPTPε expression. By quantitative real-time PCR (RT-qPCR), we showed a slight upregulation of cyt-PTPε mRNA expression following LTD4 stimulation (Fig. 1A). Cyt-PTPε protein expression was significantly upregulated following a 24-h stimulation, as demonstrated by western blot densitometry analysis (Fig. 1B).
We also examined the regulation of PTPε by cytokines that are important in the pathophysiologic context of asthma. In lung inflammation, in addition to cys-LTs, multiple Th2 polarizing cytokines are secreted and could modulate PTPε expression. Given that some of these cytokines are used in the polarization protocols for hMDMs, it was important to determine if they had direct effects on PTPε expression. Fig. 1C,D shows an upregulation of cyt-PTPε mRNA and cyt-PTPε protein expression with IL-4 stimulation. Intriguingly, a similar pattern of PTPε upregulation was seen with both IL-4 and LTD4 stimulation. Since it had been shown that IL-4 can upregulate cys-LT synthesis (Hsieh et al., 2001), we investigated the potential involvement of cys-LTs in IL-4-stimulated upregulation of PTPε mRNA expression. When monocytes were pretreated with a leukotriene synthesis inhibitor (MK886), IL-4-induced upregulation of PTPε mRNA expression was completely abolished (Fig. 1E). The Th2 cytokines IL-13 and IL-5, on the other hand, had no modulatory effect on PTPε expression (Fig. S1A,B). Moreover, no involvement of these cytokines has been noted in cys-LT production.
We also examined whether pro-inflammatory cytokines, which may be involved in Th1 polarization, could also modulate PTPε expression. As presented in Fig. 2A,B, a time-dependent upregulation of cyt-PTPε mRNA was observed following IFNγ stimulation. A significant upregulation of cyt-PTPε protein expression was also seen after a 24-h stimulation. Interestingly, the expression of both cyt-PTPε and RPTPε was upregulated with IL-1β stimulation (Fig. 2C); however, TNFα did not modulate their expression (Fig. S1C).
Polarization differentially modulates PTPε expression in hMDM
Alveolar macrophages represent a large proportion of the immune cells of the lung and arise from local proliferation or differentiation of monocyte precursors (Thomas et al., 1976; Landsman and Jung, 2007; Jenkins et al., 2011). In asthma, they polarize to a M2 subtype (Girodet et al., 2016; Draijer et al., 2013, 2017). Since polarizing cytokines regulated PTPε expression in primary monocytes, we examined whether differentiation and polarization of hMDMs would further modulate PTPε expression.
hMDMs were obtained following the described differentiation protocol and the expression of CD11b, CD36 and CD68 mRNA (macrophage differentiation markers) were analyzed by RT-qPCR to ascertain the differentiation state of the cells (Fig. S2A–C). hMDMs were then polarized using either IL-4 or the combination of IFNγ and lipopolysaccharide (LPS) as post-differentiation stimuli (Murray et al., 2014). These polarized macrophages, referred to as M2 and M1, respectively, were distinguishable by their phenotypic appearance, membrane receptors and chemokine gene expression. M1-polarized hMDMs presented a rounded shape and high expression of IL-15Rα and CXCL11 mRNA, whereas M2-polarized hMDMs were elongated with ruffled membrane protrusions and showed high expression of MRC-1 and CCL22 mRNA, which correlates with what has been previously published (Martinez et al., 2006) (Fig. S2D–H).
As shown in Fig. 3A, RT-qPCR on M1-polarized hMDMs revealed increased cyt-PTPε mRNA expression compared to that in non-polarized hMDMs (Mφ). In contrast, RPTPε mRNA expression was significantly decreased with M1 polarization with no change with M2 polarization. However, western blot densitometry analysis showed a different PTPε protein expression pattern. Quantification of cyt-PTPε and RPTPε protein expression in polarized hMDMs demonstrated the upregulation of cyt-PTPε only in M2-polarized hMDMs (Fig. 3B). Moreover, cyt-PTPεPD1 expression, a splice form of cyt-PTPε, found only in monocytic cells (Wabakken et al., 2002) and previously identified in human monocytes according to its predicted molecular mass (Lapointe et al., 2019), was significantly upregulated in M1-polarized hMDMs (Fig. 3C). As for RPTPε, a reduced expression was found in M1-polarized hMDMs, whereas a trend towards a higher expression of the glycosylated form of RPTPε (gly-RPTPε) (Fig. S3) was found in M2-polarized hMDMs. Interestingly, the glycosylated forms of gly-RPTPε were predominantly found in M2-polarized hMDMs and this post-translational modification was not observed in monocytes.
PTPε is involved in cell adhesion
Given that PTPε is important for osteoclast adhesion and that monocytes must be recruited to the inflammatory environment of the lung to differentiate into macrophages, we examined whether monocyte adhesion could modulate PTPε expression (Gerhardt and Ley, 2015).
Here, we show that monocyte adhesion considerably increased PTPε expression. A significant upregulation of PTPε was observed in the interval between monocyte isolation [day (D)0] and overnight incubation (D1). As shown in Fig. 4A,B, both cyt-PTPε and RPTPε mRNA and cyt-PTPε protein expression were upregulated during overnight adherence. However, when adherence was prevented by using low-binding tubes or continuous stirring, there was no increased expression of PTPε (Fig. S4). This treatment was without any significant effect on PTP-1B expression, a phosphatase used as a control.
In order to verify the link between PTPε and monocyte adhesion, we used PTPε-specific siRNAs (siPTPε). We found that siPTPε preferentially reduced RPTPε expression in transfected monocytes (Fig. S5A) and resulted in a reduced cell adhesion when compared with control siRNA (siCTRL)-transfected cells (Fig. 4C), suggesting the involvement of RPTPε in monocyte adhesion.
PTPε is involved in migration
Since PTPε is involved in cell adhesion and its expression is regulated during hMDM polarization and adhesion processes, it was relevant to study the role of the phosphatase in LTD4-induced migration. Myeloid cell migration requires actin rearrangement as cells spread and contract throughout their movement. We used the scratch assay to compare the migration capacities of polarized hMDMs. In addition, since LTD4 has been shown to induce actin reorganization through Rho (Saegusa et al., 2001; Massoumi et al., 2002), the ROCK inhibitor Y-27632 was used to inhibit this signaling pathway.
M2-polarized hMDMs migrated more into the scratched area, with 64.25% of the surface being filled as compared to Mφ and M1-polarized hMDMs which showed filled areas of 43.14% and 9.39%, respectively, at 24 h following the scratch (Fig. 5). Mφ hMDMs have a relatively low mobility, LTD4 did not significantly increase their migration, whereas ROCK inhibition with Y-27632 enhanced their mobility. M1-polarized hMDMs were mostly immobile. On the other hand, while LTD4 stimulation significantly increased M2-polarized hMDM migration, ROCK inhibition had no further impact, thus suggesting that ROCK activity could be modulated through LTD4 stimulation in these cells. Moreover, a significant decrease in LTD4-induced migration of siPTPε-transfected M2-polarized hMDMs was observed in a scratch assay – representing a 2D migration (Fig. 6A,B) – and 3D migration in Matrigel® Matrix (Fig. 6C,D).
PTPε is involved in podosome organization in M2-hMDMs
PTPε has been shown to regulate podosome organization in murine osteoclasts (Chiusaroli et al., 2004; Granot-Attas et al., 2009; Finkelshtein et al., 2014), cells which are derived from the same myeloid lineage as macrophages. Interestingly, it has previously been shown that M2-polarized hMDMs are the only ones to use podosomes to move via mesenchymal migration (Cougoule et al., 2012). We therefore explored the role of PTPε in podosome formation in these differentiated cells.
Following transfection with siPTPε, a different organization of podosomes was observed in M2-polarized hMDMs, when compared with siCTRL-transfection, whereas podosome organization in Mφ and M1-polarized hMDMs showed no difference (Fig. 7A). siCTRL-transfected M2-polarized hMDMs showed a homogeneous distribution of podosomes on the adherent membrane, but siPTPε-transfected M2-polarized hMDMs showed podosome clusters unevenly distributed throughout the cell and in reduced numbers. This uneven distribution was also observed following LTD4 stimulation. However, ROCK inhibition allowed the recovery of podosome distribution, organization and numbers in siPTPε-transfected M2-polarized hMDMs (Fig. 7B,C).
ROCK2 phosphorylation status depends on RPTPε
Following the identification of a role for PTPε in migration in M2-polarized hMDMs, we were interested in understanding the signaling pathways leading to this migration. Since Y-27632 inhibits ROCK activation and facilitates mesenchymal migration (Gui et al., 2014), the phosphorylation status of this kinase was investigated. M2-polarized hMDMs were transfected with siPTPε and stimulated with LTD4 for 0 to 60 min. A statistically significant increase of ROCK2 Tyr-722 phosphorylation (at the inhibitory site) was seen following siPTPε transfection when compared with siCTRL (Fig. 8A), suggesting that decreased presence of PTPε results in decreased activity of ROCK2.
HEK-293 cells stably transfected with CysLT1R (HEK-LT1), allowed us to study the role of the two PTPε isoforms, independently. HEK-LT1 were transiently transfected with cyt-PTPε, RPTPε or an empty vector (pcDNA3) and stimulated with LTD4 for 0 to 60 min. As determined by western blot densitometry, an increase in phosphorylation of the inhibitory ROCK2 Tyr-722 residue was observed with a maximum between 20 and 30 min for the control (pcDNA3) and the cyt-PTPε transfection. However, a statistically significant decrease of ROCK2 Tyr-722 phosphorylation was seen following RPTPε transfection when compared with cyt-PTPε and control (pcDNA3) (Fig. 8B).
Since only RPTPε inhibited LTD4-induced ROCK2 Tyr-722 phosphorylation, and the majority of this isoform is glycosylated in M2-polarized hMDMs, we were interested in investigating whether glycosylation was involved in RPTPε activity. Extracellular putative N-glycosylated residues (residue 23 and 30) of RPTPε were therefore mutated from asparagine to glutamine residues (N23Q and N30Q). Each individual mutant was glycosylated at a lower level than the WT protein, indicating that both residues are glycosylated (Fig. S6B). The mutants were expressed at the same level and in the same cellular localization as the wild-type construction (WT) (Fig. S6C,D). We then examined the effect of the RPTPε mutants on LTD4-stimulated ROCK2 Tyr-722 phosphorylation. As shown in Fig. 8C, transfection of both mutants resulted in higher ROCK2 Tyr-722 phosphorylation compared to RPTPε-WT. Thus ROCK2 was less active in the presence of the glycosylation mutants than in the presence of the WT phosphatase. Interestingly, mutation of both residues produced a protein whose activity towards ROCK2 phosphorylation was comparable to the single mutants (results not shown). Thus, glycosylation of RPTPε has at least a partial role in its activity since the mutation of the residues N23 and N30 decreases the effect of RPTPε on the phosphorylation levels of ROCK2 Tyr-722.
DISCUSSION
One of the main mechanisms that regulate cellular processes is the reversible phosphorylation of proteins by kinases and phosphatases. Several studies have shown that PTPs could play essential roles in physiological processes (Fischer et al., 1991) and, therefore, be involved in numerous diseases (Hendriks et al., 2013). PTPε was of interest here since it is relevant in allergic asthma (Tremblay et al., 2008) and our previous results suggested that it is involved in inflammatory processes modulated by cys-LTs. In addition, whereas previously published data showed that PTPε isoforms were expressed in a non-overlapping expression patterns in murine cell types (Elson and Leder, 1995; Gil-Henn et al., 2000), we showed that both cyt-PTPε and RPTPε were both expressed in human primary monocytes (Lapointe et al., 2019) but their targets were divergent. Thus, the expression pattern and its possible functional significance were the focus of this study.
In the present work, we show that polarizing cytokines upregulate cyt-PTPε and RPTPε expression. Interestingly, among the Th2 polarization agents tested, IL-4 was shown to upregulate PTPε expression by a cys-LT-dependent mechanism. This is consistent with our previous results where we identified PTPε as a CysLT1R signaling partner and confirmed its role in LTD4-induced signaling (Lapointe et al., 2019). IFNγ and IL-1β also upregulated both cyt-PTPε and RPTPε expression. IL-1β had also been shown to upregulate cyt-PTPε in U373-MG astrocytoma cells (Schumann et al., 1998) but this is the first demonstration of PTPε upregulation by the other cytokines.
In addition, expression of PTPε isoforms differs in M1- and M2-polarized hMDMs. Specifically, M2-polarized hMDMs expressed more of the highly glycosylated form of RPTPε and siPTPε-transfected M2-polarized hMDMs also migrated less, a possible consequence of uneven distribution of podosomes through inhibition of LTD4-induced ROCK2 Tyr-722 dephosphorylation by RPTPε.
It has been shown that macrophage-like terminal differentiation of HL-60 and myeloid leukemia M1 cells increases cyt-PTPε but not RPTPε expression (Tanuma et al., 1999). We have observed that differentiation of human monocytes into macrophages upregulates RPTPε but not cyt-PTPε mRNA expression (F.L., unpublished results), indicating that both the cell type and stimulus may influence the expression of the two isotypes differentially. We therefore further examined the expression pattern of PTPε isoforms in polarized hMDMs. Interestingly, even though IL-4-stimulated monocytes only increased their expression of cyt-PTPε, M2-polarized hMDMs expressed higher levels of both RPTPε and cyt-PTPε when compared to M1-polarized hMDMs. In addition, M2-polarized hMDMs expressed more of the gly-RPTPε forms than Mφ and M1-polarized hMDMs. Moreover, monocytes, which do not usually express gly-RPTPε (Lapointe et al., 2019), increased their expression of this form following adhesion. Downregulation of RPTPε using PTPε-specific siRNA, reduced monocyte adhesion, further supporting a role for the phosphatase in the adhesion processes.
Interestingly, a role for PTPε in myeloid cell adhesion has been suggested. Murine PTPε−/− osteoclasts show defective bone adhesion and resorption as a consequence of disorganized podosomes (Granot-Attas et al., 2009; Chiusaroli et al., 2004). Our results showed that when PTPε expression was reduced in siPTPε-transfected M2-polarized hMDMs, their podosomes were decreased in numbers and found in clusters instead of being evenly distributed. Interestingly, this was true only in M2-polarized hMDMs, whereas in Mφ or M1-polarized hMDMs the podosomes remained evenly distributed in spite of siPTPε transfection. We speculated that the higher expression of the gly-RPTPε might have a role in our findings, as this was one difference between the three subpopulations.
In murine osteoclasts, cyt-PTPε, the only isoform expressed in these cells, regulates ROCK activity through Rho signaling, leading to correct assembly, dynamics and subcellular organization of podosomes, which is crucial for efficient bone resorption (Granot-Attas et al., 2009; Chiusaroli et al., 2004). Macrophages also naturally form podosomes, but only M2-polarized hMDMs were shown to use podosomes to migrate (Cougoule et al., 2012). In our experiments, ROCK inhibition allowed a recovery of podosome distribution and organization in these cells.
In order to understand the role of RPTPε in LTD4-induced ROCK phosphorylation, we studied ROCK2 Tyr-722 phosphorylation levels. Phosphorylation of Tyr-722 on ROCK2 is inhibitory, so with higher levels of phosphorylation of this residue, the kinase is inhibited. In siPTPε-transfected M2-polarized hMDMs, phosphorylation of ROCK2 Tyr-722 was increased with LTD4 stimulation. Conversely, expression of RPTPε in HEK-LT1 cells resulted in the inhibition of LTD4-induced ROCK2 Tyr-722 phosphorylation, potentially resulting in an activated kinase.
ROCK2 activity is regulated by various mechanisms. Of these, phosphorylation is the most studied. Phosphorylation of Ser-1366 correlates with increased kinase activity but phosphorylation of Tyr-722 has been shown to be inhibitory as it prevents RhoA-mediated ROCK2 activation (Lee et al., 2010; Lee and Chang, 2008).
Although ROCK2 Tyr-722 phosphorylation correlates with RPTPε downregulation or overexpression, ROCK2 Tyr-722 may not be a direct substrate of RPTPε. RPTPε is known to activate Src by dephosphorylating its inhibitory Tyr-527 residue (Gil-Henn and Elson, 2003; Berman-Golan and Elson, 2007; Granot-Attas et al., 2009). Src, meanwhile, also activates SHP-2 (Salmond and Alexander, 2006), which, in turn, is a cytosolic PTP that dephosphorylates ROCK2 Tyr-722 and thus allows its activation by RhoA (Lee and Chang, 2008). By activating Src, RPTPε may therefore allow SHP-2 activation through tyrosine-phosphorylated ligand interaction and finally, SHP-2-induced ROCK2 Tyr-722 dephosphorylation. RPTPε activity would then lead to myosin light chain phosphorylation, actin contraction and podosome organization.
LTD4-induced ROCK2 Tyr-722 phosphorylation was decreased with WT RPTPε expression compared to control or cyt-PTPε, but increased phosphorylation was found when either the N-glycosylated Asn-23 or Asn-30 residue was mutated to glutamine. This indicates that, at least in part, glycosylation of RPTPε is important for dephosphorylation of ROCK2 Tyr-722. However, additional PTP experiments would be necessary to establish the role of glycosylation in RPTPε activity. We were not successful at directly examining the phosphatase activity in vitro, in spite of many different attempts at optimization (dissociation from magnetic beads and agarose protein G, pH modification; Hamel-Côté et al., 2019). Interestingly, RPTPα, member of the same PTP subfamily as RPTPε, only dephosphorylates the insulin receptor when glycosylated (Lammers et al., 1997). In addition, whereas the activity of RPTPε is regulated by phosphorylation in murine Neu-induced mammary tumor cells, only the glycosylated form of the phosphatase is phosphorylated at the Tyr-695 residue. The authors suggested that only the glycosylated forms of RPTPε would activate Src (Berman-Golan and Elson, 2007).
In conclusion, the present work demonstrates a unique role for RPTPε in regulating ROCK2 Tyr-722 phosphorylation (summarized in Fig. 8D) and shows that this role is enhanced through the glycosylation of the asparagine residues. Interestingly, among the myeloid cell types examined in this study, M2-polarized hMDMs expressed the glycosylated form of RPTPε, which is suggested to be involved in appropriate podosome organization through ROCK2 signaling leading to M2-polarized hMDM migration. The mutual interactions of PTPε and CysLT1R signaling in inflammatory diseases, and especially asthma, deserve further studies since that would potentially lead to novel intervention models.
MATERIALS AND METHODS
Antibodies and reagents
Antibodies against the multiple PTPε isoforms (ab123345) and phosphorylated ROCK2 Y-722 (ab182649) were purchased from Abcam® PLC (Toronto, ON, Canada). Total ROCK2 antibodies were from Santa Cruz Biotechnologies, Inc. (sc-398519, Santa Cruz, CA). Specific antibodies against vinculin (V4505) and actin (A5060) were purchased from Sigma-Aldrich® (Oakville, ON, Canada). Secondary antibodies conjugated to the horseradish peroxidase (HRP) (7074, 7076) used in western blot detection were from Cell Signaling Technology® (Danvers, MA). Alexa Fluor™ 488–phalloidin was from Thermo Fisher Scientific (Burlington ON, Canada) and DAPI, from Molecular Probes® (Burlington, ON, Canada).
LTD4 and MK886, a 5-lipoxygenase activating protein inhibitor, were purchased from Cayman Chemical Company (Ann Arbor, MI). Y-27632 was from Sigma-Aldrich®. Matrigel® Matrix was from Corning Inc. (Tewksbury, MA, USA).
Leupeptin, aprotinin, phenylmethanesulfonyl fluoride (PMSF), pepstatin A, and the Phosphatase Inhibitor Cocktail II (PICII) were purchased from Sigma-Aldrich®. Sodium fluoride (NaF) was from Thermo Fisher Scientific, sodium orthovanadate (Na3VO4), from Bio Basic Canada Inc. (Markham, ON, Canada), and Complete Mini EDTA-free protease inhibitor tablets were from Roche Diagnostics (Laval, QC, Canada).
Finally the transfection reagent used for transient transfection was TransIT®-LT1 (Mirus® Bio LLC, Madison, WI).
Plasmids
Plasmids used in this work were cyt-PTPε and RPTPε, stabilized by a 5′ β-globin intron and under the control of a CMV promoter, subcloned into a pcDNA3 vector (Invitrogen, Carlsbad, CA, USA). RPTPε was also subcloned in pGFP2-N3(h) vector (Perkin Elmer Canada, Woodbridge, ON, Canada) in order to yield C-terminus-tagged RPTPε_GFP2 in which asparagine residues 23 and 30 were mutated to glutamine by site-directed mutagenesis with the Q5® Site-Directed Mutagenesis Kit (New England Biolabs®, Whitby, ON, Canada) using the following primers (the mutated codon is shown in lowercase): RPTPε_N23Q forward 5′-TCTCAGGGGCcaaGAGACCACTGCCGAC-3′ and RPTPε_N23Q reverse 5′-GCCCTGGCGAGCGGCAAG-3′; RPTPε_N30Q forward 5′-TGCCGACAGCcaaGAGACAACCAC-3′, and RPTPε_N30Q reverse 5′-GCCCTGGCGAGCGGCAAG-3′.
siRNAs and Cy™3-tagged siRNAs used in this study were from Ambion® (Burlington, ON, Canada; cat. number: 4390828, code ADFARDD).
Cells
HEK-293 cells (ATCC®) stably expressing CysLT1R (HEK-LT1), as described in Thompson et al. (2006), were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco®, Burlington, ON, Canada), supplemented with 5% fetal bovine serum (FBS) (PAA, Piscataway, NJ). Experiments were performed 48 h post-transfection of these cells. HEK-LT1 cells are regularly controlled for their expression of CysLT1R and tested for mycoplasma contamination.
Human primary monocytes were isolated from peripheral blood mononuclear leukocytes obtained from healthy donors after informed written consent, in accordance with a Université de Sherbrooke Human Ethics Review Board-approved protocol (#2016-1167-CysLT), adhering to the Helsinki agreement. Cells were processed as previously described (Lapointe et al., 2019). Isolated monocytes were suspended in RPMI 1640 medium (Gibco®) supplemented with 5% FBS. Experiments were performed after an overnight incubation following their isolation or 48 h post-transfection.
hMDMs were differentiated in 12- or 96-well non-treated culture plates at 5×105 cells/ml or on pre-treated poly-L-lysine (0.1 mg/ml) (Sigma-Aldrich®) coverslips at 1.25×105 cells/ml and obtained following 8 days of differentiation in RPMI 1640 medium containing 10% FBS and 20 ng/ml M-CSF (recombinant human M-CSF from E. coli: PeproTech Canada, Montreal, QC, Canada; 300-25). On day 7, medium was replaced with fresh RPMI plus 5% FBS. M1 and M2 macrophages were obtained following a 18 h polarization using, respectively, 100 ng/ml lipopolysaccharide (LPS from E. coli O127:B8, Sigma-Aldrich®; L-3129) plus 10 ng/ml IFNγ (recombinant human IFNγ from E.coli: PeproTech Canada; 300-02) or 20 ng/ml IL-4 (recombinant human IL-4 from E. coli: PeproTech Canada; 200-04).
Cells were incubated under normal conditions in a humidified atmosphere with 5% CO2 at 37°C.
Adhesion assays
Following their isolation, 4×106 human primary monocytes were transfected with 150 pmole siRNAs for 42 h. Cells were then counted and seeded in a round-bottom polypropylene tube. Following a 6-h incubation, non-adherent cells were washed twice with PBS and resting adherent cells were fixed with 2% paraformaldehyde and stained with Crystal Violet (0.05% Crystal Violet, Sigma-Aldrich®, 25% EtOH). Cells were washed with water until no more dye was present. A 1% SDS solution was added to the tubes to solubilize the stain and tubes were agitated on orbital shaker until color was uniform. Supernatants were transferred in a 96-well plate and absorbance was read at 570 nm.
Scratch assays
hMDM migration activity was assessed with scratch assays. Following an 18-h polarization time, the cell monolayer was scratched with a sterile 10 µl micropipette tip. The scratches were immediately imaged for the zero-time point using a Leica DM-IRBE inverted microscope. Cells were subsequently incubated with Y-27632 (20 µM) for 15 min followed by a 24-h incubation with 100 nM LTD4 or its vehicle (EtOH). Photographs were taken following the 24 h stimulating time. The images were used to measure the scratched area at zero-time point (T0) and 24 h following the scratches (T24), using a macro (Montpellier RIO Imaging) for ImageJ. For each condition, five photographs were taken per well and the means were used in the formula ((T0−T24)/T0)×100 to calculate the percentage of the scratch closure. Filled areas are either expressed as percentage of initial or as fold change compared to EtOH.
Three-dimensional migration assays
hMDM three-dimensional migration activity was assessed in Matrigel® Matrix. hMDMs were differentiated in 96-well plates, transfected with siRNAs (siCTRL or siPTPε), and polarized to M2 as previously described. Following polarization, culture medium was removed and 50 µl Matrigel® Matrix was added directly over the cells. The matrix was allowed to polymerize for 30 min and was rehydrated for 2 h with RPMI plus 5% de-complemented autologous serum at 37°C plus 5% CO2. For the migration assay, hydration medium was removed and 25 µl of 0.3% agar containing LTD4 (100 nM), or its vehicle (EtOH), were added over the matrix. Cell migration was then allowed at 37°C plus 5% CO2 for 48 h. Cells were then fixed in the matrix with 0.5% paraformaldehyde, permeabilized with 0.1% Triton and a DAPI staining was used to visualize nuclei. Quantification of cell migration was performed using an Olympus FluoView FV1000 confocal microscope (Center Valley, PA). Photographs were taken with a 10× objective at constant 25 µm intervals from the bottom of the wells to the top of the matrix. Nuclei were counted with Image-Pro Plus 6.0 from MediaCybernetics (Bethesda, MD). The percentage of migration was obtained as the ratio of cells counted in the first 50 µm within the matrix of the total number of cells.
Laser scanning confocal microscopy for podosome imaging
Cells were differentiated on pre-treated poly-L-lysine (0.1 mg/ml) coverslips. Adherent cells were fixed with 2% paraformaldehyde and permeabilized with 0.1% saponin. A 2% BSA solution was used to block non-specific sites. Alexa Fluor™ 488–phalloidin (1:500) was used to visualize F-actin and DAPI staining (1:1000) was used to visualize nuclei. Finally, cells transfected with the Cy™3-tagged siRNAs were visualized and analyzed using an Olympus FluoView FV1000 confocal microscope. Captured images were further analyzed using Image-Pro Plus 6.0 from MediaCybernetics.
RNA isolation and RT-PCR
Total RNA was purified using Trizol® Reagent (Thermo Fisher Scientific) according to the manufacturer's instructions using the conventional phenol/chloroform technique. To exclude genomic DNA contamination, RNA was digested with gDNA Wipeout, provided in the QuantiTect® Reverse Transcription Kit (Qiagen Inc.). First-strand cDNA synthesis was performed on 1 µg RNA using random primers supplied in the above-mentioned kit.
Real-time quantitative PCR
RT-qPCR was performed using the Rotor Gene RG-3000 from Corbett Research (San Francisco, CA, USA) as previously described (Lapointe et al., 2019). Data analysis was performed according to the 2ΔΔCT method (Dussault and Pouliot, 2006). The primer sequences were as follows: RPL13A forward 5′-GTGCGTCTGAAGCCTACAAG-3′, RPL13A reverse 5′-TCTTCTCCACGTTCTTCTCG-3′, GAPDH forward 5′-TCAACGGATTTGGTCGTATTGG-3′, GAPDH reverse 5′-GATGGGATTTCCATTGATGACA-3′, cyt-PTPε forward 5′-CTTTTCCCGGCTCACCTGGTTC-3′, cyt-PTPε reverse 5′-GGATGGGAAAATACTTCTTGG-3′, RPTPε forward 5′-GCCTACTTCTTCAGGTTCAGG-3′, RPTPε reverse 5′-GGATGGGAAAATACTTCTTGG-3′.
Cyt-PTPε and RPTPε mRNA expression were analyzed by RT-qPCR and expressed as 2ΔΔCT over GAPDH mRNA expression in human primary monocytes. However, RPL13A mRNA was used as a housekeeping control when studying mRNA expression in hMDMs since its expression was more stable between the multiple differentiation and polarization states when compared to GAPDH.
Western blotting
Western blotting was performed as previously described (Lapointe et al., 2019). HEK-LT1 cells were lysed using buffer containing 1% NP-40 (20 mM Tris-HCl pH 8.0, 137 mM NaCl, 1% NP-40 and 10% glycerol) and containing the inhibitors 1 mM PMSF, 2 µg/ml aprotinin, 10 µg/ml leupeptin, 1 µg/ml pepstatin A, 10 mM NaF, 1 mM Na3VO4, PICII 1× and a Complete Mini EDTA free protease inhibitor tablet, for 30 min on ice. Total protein concentrations were quantified using Pierce™ Coomassie Plus Assay Kit (Thermo Fisher Scientific™) and 30 µg were separated on a 10% SDS-PAGE and transferred onto a 0.45 µM nitrocellulose membrane (GE Healthcare Life Sciences). The membrane was incubated with the primary antibodies(PTPε, 1:1000; vinculin, 1:2500; actin, 1:2500; p-ROCK2, 1:1000) overnight at 4°C in 1× TBS with 0.05% Tween-20 and 5% BSA for phosphorylated proteins or a 1× TBS with 0.05% Tween-20 and 5% free-fat milk solution for non-phosphorylated proteins. Proteins were detected after to a 30-min incubation with secondary antibodies labeled with HRP (anti-mouse-Ig, 1:2500) (anti-rabbit-Ig, 1:2500) using an ECL detection system (GE Healthcare Life Sciences) on a ChemiDoc™ MP Imaging System (Bio-Rad, Mississauga, ON, Canada). Signal intensity was quantified by densitometry using Image Lab. Following phosphorylated protein detection, membranes were stained for total ROCK2 protein (ROCK2, 1:1000) after a 20-min stripping protocol (200 mM glycine, 3.5 mM SDS, 1% Tween-20 pH 2.2).
Statistical analysis
One and two-way ANOVA and Student's t-test (two-tailed) analyses with correction for multiple comparisons using statistical hypothesis testing were performed when required using Prism 7.0 software (GraphPad). A P value of <0.05 was considered statistically significant.
Acknowledgements
The authors wish to thank Geneviève Hamel-Côté for the pertinent discussions and Leonid Volkov for his technical support throughout the course of this work.
Footnotes
Author contributions
Conceptualization: F.L., M.R.-P., J.S.; Methodology: F.L., S.T., J.R., E.B.; Validation: S.T., J.R.; Formal analysis: F.L., S.T., J.R., M.R.-P.; Resources: E.B., J.S.; Data curation: F.L., S.T., J.R., E.B., J.S.; Writing - original draft: F.L.; Writing - review & editing: F.L., M.R.-P., J.S.; Supervision: M.R.-P., J.S.; Project administration: M.R.-P., J.S.; Funding acquisition: M.R.-P., J.S.
Funding
This research was supported by the Canadian Institutes of Health Research [grant MOP-142481] to J.S. and M.R.-P. F.L. is the recipient of a studentships from the Fonds de Recherche du Québec - Santé. The work was performed at the Centre de Recherche Clinique du Centre Hospitalier Universitaire de Sherbrooke, funded by the Fonds de la Recherche du Québec en Santé, of which M.R.-P. and J.S. are members.
References
Competing interests
The authors declare no competing or financial interests.